| UniProt ID | CPSF6_HUMAN | |
|---|---|---|
| UniProt AC | Q16630 | |
| Protein Name | Cleavage and polyadenylation specificity factor subunit 6 {ECO:0000305} | |
| Gene Name | CPSF6 {ECO:0000312|HGNC:HGNC:13871} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 551 | |
| Subcellular Localization | Nucleus . Nucleus, nucleoplasm . Nucleus speckle . Cytoplasm . Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm) (PubMed:19864460). | |
| Protein Description | Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. [PubMed: 9659921] | |
| Protein Sequence | MADGVDHIDIYADVGEEFNQEAEYGGHDQIDLYDDVISPSANNGDAPEDRDYMDTLPPTVGDDVGKGAAPNVVYTYTGKRIALYIGNLTWWTTDEDLTEAVHSLGVNDILEIKFFENRANGQSKGFALVGVGSEASSKKLMDLLPKRELHGQNPVVTPCNKQFLSQFEMQSRKTTQSGQMSGEGKAGPPGGSSRAAFPQGGRGRGRFPGAVPGGDRFPGPAGPGGPPPPFPAGQTPPRPPLGPPGPPGPPGPPPPGQVLPPPLAGPPNRGDRPPPPVLFPGQPFGQPPLGPLPPGPPPPVPGYGPPPGPPPPQQGPPPPPGPFPPRPPGPLGPPLTLAPPPHLPGPPPGAPPPAPHVNPAFFPPPTNSGMPTSDSRGPPPTDPYGRPPPYDRGDYGPPGREMDTARTPLSEAEFEEIMNRNRAISSSAISRAVSDASAGDYGSAIETLVTAISLIKQSKVSADDRCKVLISSLQDCLHGIESKSYGSGSRRERSRERDHSRSREKSRRHKSRSRDRHDDYYRERSRERERHRDRDRDRDRERDREREYRHR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 33 | Phosphorylation | GHDQIDLYDDVISPS CCCCCCCCCCCCCCC | 13.32 | 26074081 | |
| 38 | Phosphorylation | DLYDDVISPSANNGD CCCCCCCCCCCCCCC | 16.79 | 26657352 | |
| 40 | Phosphorylation | YDDVISPSANNGDAP CCCCCCCCCCCCCCC | 36.52 | 26074081 | |
| 52 | Phosphorylation | DAPEDRDYMDTLPPT CCCCCCCCHHCCCCC | 9.59 | 23532336 | |
| 55 | Phosphorylation | EDRDYMDTLPPTVGD CCCCCHHCCCCCCCC | 25.32 | 19664995 | |
| 74 | Phosphorylation | GAAPNVVYTYTGKRI CCCCCEEEEECCCEE | 6.97 | 21945579 | |
| 75 | Phosphorylation | AAPNVVYTYTGKRIA CCCCEEEEECCCEEE | 11.73 | 21945579 | |
| 76 | Phosphorylation | APNVVYTYTGKRIAL CCCEEEEECCCEEEE | 8.87 | 21945579 | |
| 77 | Phosphorylation | PNVVYTYTGKRIALY CCEEEEECCCEEEEE | 28.55 | 21945579 | |
| 79 (in isoform 3) | Ubiquitination | - | 32.60 | 21890473 | |
| 79 (in isoform 2) | Ubiquitination | - | 32.60 | 21890473 | |
| 79 (in isoform 1) | Ubiquitination | - | 32.60 | 21890473 | |
| 79 | Ubiquitination | VVYTYTGKRIALYIG EEEEECCCEEEEEEC | 32.60 | 27667366 | |
| 79 | Acetylation | VVYTYTGKRIALYIG EEEEECCCEEEEEEC | 32.60 | 23954790 | |
| 137 | Phosphorylation | GVGSEASSKKLMDLL ECCCHHHHHHHHHHH | 40.64 | 21712546 | |
| 138 | Malonylation | VGSEASSKKLMDLLP CCCHHHHHHHHHHHC | 47.64 | 26320211 | |
| 138 | Acetylation | VGSEASSKKLMDLLP CCCHHHHHHHHHHHC | 47.64 | 25953088 | |
| 138 | Ubiquitination | VGSEASSKKLMDLLP CCCHHHHHHHHHHHC | 47.64 | 33845483 | |
| 146 | Ubiquitination | KLMDLLPKRELHGQN HHHHHHCHHHHCCCC | 59.48 | 29967540 | |
| 157 | Phosphorylation | HGQNPVVTPCNKQFL CCCCCCCCCCCHHHH | 23.51 | 30916345 | |
| 161 (in isoform 1) | Ubiquitination | - | 49.49 | 21890473 | |
| 161 (in isoform 3) | Ubiquitination | - | 49.49 | 21890473 | |
| 161 (in isoform 2) | Ubiquitination | - | 49.49 | 21890473 | |
| 161 | Acetylation | PVVTPCNKQFLSQFE CCCCCCCHHHHHHHH | 49.49 | 25953088 | |
| 161 | Ubiquitination | PVVTPCNKQFLSQFE CCCCCCCHHHHHHHH | 49.49 | 27667366 | |
| 165 | Phosphorylation | PCNKQFLSQFEMQSR CCCHHHHHHHHHHCC | 33.83 | 17525332 | |
| 169 | Sulfoxidation | QFLSQFEMQSRKTTQ HHHHHHHHHCCCCCC | 4.65 | 21406390 | |
| 174 | Phosphorylation | FEMQSRKTTQSGQMS HHHHCCCCCCCCCCC | 29.02 | 22210691 | |
| 175 | Phosphorylation | EMQSRKTTQSGQMSG HHHCCCCCCCCCCCC | 24.63 | 22210691 | |
| 177 | Phosphorylation | QSRKTTQSGQMSGEG HCCCCCCCCCCCCCC | 28.97 | 28111955 | |
| 180 | Sulfoxidation | KTTQSGQMSGEGKAG CCCCCCCCCCCCCCC | 6.75 | 30846556 | |
| 181 | Phosphorylation | TTQSGQMSGEGKAGP CCCCCCCCCCCCCCC | 26.29 | 22210691 | |
| 185 (in isoform 2) | Ubiquitination | - | 45.96 | 21890473 | |
| 185 | Ubiquitination | GQMSGEGKAGPPGGS CCCCCCCCCCCCCCC | 45.96 | 27667366 | |
| 185 | Acetylation | GQMSGEGKAGPPGGS CCCCCCCCCCCCCCC | 45.96 | 25953088 | |
| 185 (in isoform 1) | Ubiquitination | - | 45.96 | 21890473 | |
| 192 | Phosphorylation | KAGPPGGSSRAAFPQ CCCCCCCCCCCCCCC | 23.67 | 28111955 | |
| 193 | Phosphorylation | AGPPGGSSRAAFPQG CCCCCCCCCCCCCCC | 29.25 | 28111955 | |
| 194 | Methylation | GPPGGSSRAAFPQGG CCCCCCCCCCCCCCC | 31.47 | - | |
| 202 | Methylation | AAFPQGGRGRGRFPG CCCCCCCCCCCCCCC | 38.16 | - | |
| 204 | Methylation | FPQGGRGRGRFPGAV CCCCCCCCCCCCCCC | 31.58 | - | |
| 206 | Methylation | QGGRGRGRFPGAVPG CCCCCCCCCCCCCCC | 32.97 | - | |
| 258 (in isoform 2) | Phosphorylation | - | 12.27 | 24117733 | |
| 381 | Phosphorylation | DSRGPPPTDPYGRPP CCCCCCCCCCCCCCC | 56.21 | 28796482 | |
| 384 | Phosphorylation | GPPPTDPYGRPPPYD CCCCCCCCCCCCCCC | 28.69 | 28796482 | |
| 390 | Phosphorylation | PYGRPPPYDRGDYGP CCCCCCCCCCCCCCC | 24.85 | 28796482 | |
| 392 | Methylation | GRPPPYDRGDYGPPG CCCCCCCCCCCCCCC | 33.76 | - | |
| 395 | Phosphorylation | PPYDRGDYGPPGREM CCCCCCCCCCCCCCC | 34.06 | 28796482 | |
| 404 | Phosphorylation | PPGREMDTARTPLSE CCCCCCCCCCCCCCH | 19.41 | 29255136 | |
| 407 | Phosphorylation | REMDTARTPLSEAEF CCCCCCCCCCCHHHH | 26.56 | 29255136 | |
| 410 | Phosphorylation | DTARTPLSEAEFEEI CCCCCCCCHHHHHHH | 35.64 | 23927012 | |
| 418 | Sulfoxidation | EAEFEEIMNRNRAIS HHHHHHHHHHCHHHC | 4.33 | 28183972 | |
| 425 | Phosphorylation | MNRNRAISSSAISRA HHHCHHHCHHHHHHH | 19.77 | 18452278 | |
| 426 | Phosphorylation | NRNRAISSSAISRAV HHCHHHCHHHHHHHH | 20.06 | 18452278 | |
| 427 | Phosphorylation | RNRAISSSAISRAVS HCHHHCHHHHHHHHH | 23.88 | 18452278 | |
| 430 | Phosphorylation | AISSSAISRAVSDAS HHCHHHHHHHHHCCC | 17.57 | 20860994 | |
| 434 | Phosphorylation | SAISRAVSDASAGDY HHHHHHHHCCCCCCH | 26.86 | 21406692 | |
| 437 | Phosphorylation | SRAVSDASAGDYGSA HHHHHCCCCCCHHHH | 37.46 | 21406692 | |
| 441 | Phosphorylation | SDASAGDYGSAIETL HCCCCCCHHHHHHHH | 16.44 | 21406692 | |
| 443 | Phosphorylation | ASAGDYGSAIETLVT CCCCCHHHHHHHHHH | 21.61 | 21406692 | |
| 447 | Phosphorylation | DYGSAIETLVTAISL CHHHHHHHHHHHHHH | 22.03 | 21406692 | |
| 450 | Phosphorylation | SAIETLVTAISLIKQ HHHHHHHHHHHHHHH | 22.76 | 21406692 | |
| 453 | Phosphorylation | ETLVTAISLIKQSKV HHHHHHHHHHHHCCC | 22.90 | 24719451 | |
| 456 | Ubiquitination | VTAISLIKQSKVSAD HHHHHHHHHCCCCHH | 54.54 | 33845483 | |
| 459 | Ubiquitination | ISLIKQSKVSADDRC HHHHHHCCCCHHHHH | 37.40 | - | |
| 471 | Phosphorylation | DRCKVLISSLQDCLH HHHHHHHHHHHHHHH | 22.34 | 18452278 | |
| 476 | Glutathionylation | LISSLQDCLHGIESK HHHHHHHHHHHHHCC | 1.63 | 22555962 | |
| 482 | Phosphorylation | DCLHGIESKSYGSGS HHHHHHHCCCCCCCC | 25.61 | 26074081 | |
| 483 | Ubiquitination | CLHGIESKSYGSGSR HHHHHHCCCCCCCCH | 34.60 | 21963094 | |
| 484 | Phosphorylation | LHGIESKSYGSGSRR HHHHHCCCCCCCCHH | 43.96 | 26074081 | |
| 485 | Phosphorylation | HGIESKSYGSGSRRE HHHHCCCCCCCCHHH | 21.03 | 26074081 | |
| 487 | Phosphorylation | IESKSYGSGSRRERS HHCCCCCCCCHHHHH | 25.93 | 26074081 | |
| 489 | Phosphorylation | SKSYGSGSRRERSRE CCCCCCCCHHHHHHH | 29.84 | 26074081 | |
| 493 | Ubiquitination | GSGSRRERSRERDHS CCCCHHHHHHHHHHH | 38.92 | 33845483 | |
| 494 | Phosphorylation | SGSRRERSRERDHSR CCCHHHHHHHHHHHH | 33.47 | 30916345 | |
| 500 | Phosphorylation | RSRERDHSRSREKSR HHHHHHHHHHHHHHH | 35.92 | 30916345 | |
| 502 | Phosphorylation | RERDHSRSREKSRRH HHHHHHHHHHHHHHH | 48.05 | 33259812 | |
| 511 | Phosphorylation | EKSRRHKSRSRDRHD HHHHHHHHHHHHHHH | 29.39 | 30916345 | |
| 513 | Phosphorylation | SRRHKSRSRDRHDDY HHHHHHHHHHHHHHH | 45.70 | 23401153 | |
| 520 | Phosphorylation | SRDRHDDYYRERSRE HHHHHHHHHHHHHHH | 15.52 | 29449344 | |
| 520 | Ubiquitination | SRDRHDDYYRERSRE HHHHHHHHHHHHHHH | 15.52 | 21963094 | |
| 521 | Phosphorylation | RDRHDDYYRERSRER HHHHHHHHHHHHHHH | 17.00 | 29214152 | |
| 525 | Phosphorylation | DDYYRERSRERERHR HHHHHHHHHHHHHHH | 33.47 | 30916345 | |
| 539 | Phosphorylation | RDRDRDRDRERDRER HHHHHHHHHHHHHHH | 62.17 | 33259812 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPSF6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPSF6_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-407, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-404, AND MASSSPECTROMETRY. | |